| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.091 | 0.04 |